Zhejiang Yatai Pharmaceutical Co Ltd (002370) — Financial Flexibility Index
Zhejiang Yatai Pharmaceutical Co Ltd (002370) has a Financial Flexibility Index of -0.05x as of September 2025. Free cash flow of CN¥-4.19 Million (operating CF CN¥-6.29 Million minus capex CN¥2.11 Million) represents 0% of total liabilities (CN¥92.77 Million). Check Zhejiang Yatai Pharmaceutical Co Ltd strategic capital allocation to assess the company's strategic physical and investment asset allocation.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Zhejiang Yatai Pharmaceutical Co Ltd Financial Flexibility Index (2007–2025)
Historical Financial Flexibility Index trend for Zhejiang Yatai Pharmaceutical Co Ltd across 19 annual periods. See Zhejiang Yatai Pharmaceutical Co Ltd (002370) working capital ratio to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for Zhejiang Yatai Pharmaceutical Co Ltd (2007–2025)
Year-by-year free cash flow to debt coverage for Zhejiang Yatai Pharmaceutical Co Ltd. For the full company profile including market capitalisation, see 002370 market cap.
| Year | Flexibility Index | Free Cash Flow (CNY) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.21x | CN¥33.95 Million | CN¥28.90 Million | CN¥159.43 Million | ▲ +166.9% |
| 2024 | 0.08x | CN¥34.27 Million | CN¥24.35 Million | CN¥429.59 Million | ▲ +206.1% |
| 2023 | 0.03x | CN¥22.11 Million | CN¥14.65 Million | CN¥848.50 Million | ▼ -3.9% |
| 2022 | 0.03x | CN¥33.14 Million | CN¥12.04 Million | CN¥1.22 Billion | ▲ +167.6% |
| 2021 | 0.01x | CN¥11.93 Million | CN¥-3.84 Million | CN¥1.18 Billion | ▼ -76.9% |
| 2020 | 0.04x | CN¥56.89 Million | CN¥17.81 Million | CN¥1.30 Billion | ▼ -70.0% |
| 2019 | 0.15x | CN¥239.11 Million | CN¥-55.74 Million | CN¥1.64 Billion | ▼ -74.6% |
| 2018 | 0.57x | CN¥667.89 Million | CN¥36.99 Million | CN¥1.16 Billion | ▼ -20.2% |
| 2017 | 0.72x | CN¥410.33 Million | CN¥127.59 Million | CN¥569.62 Million | ▲ +405.1% |
| 2016 | 0.14x | CN¥37.89 Million | CN¥-38.05 Million | CN¥265.69 Million | ▲ +33.8% |
| 2015 | 0.11x | CN¥135.10 Million | CN¥100.93 Million | CN¥1.27 Billion | ▼ -93.5% |
| 2014 | 1.63x | CN¥164.95 Million | CN¥73.31 Million | CN¥101.21 Million | ▲ +180.2% |
| 2013 | 0.58x | CN¥53.54 Million | CN¥31.12 Million | CN¥92.04 Million | ▲ +230.0% |
| 2012 | 0.18x | CN¥20.11 Million | CN¥-10.51 Million | CN¥114.08 Million | ▼ -74.4% |
| 2011 | 0.69x | CN¥87.11 Million | CN¥48.79 Million | CN¥126.48 Million | ▲ +53.4% |
| 2010 | 0.45x | CN¥65.09 Million | CN¥-3.76 Million | CN¥145.02 Million | ▲ +19.6% |
| 2009 | 0.38x | CN¥79.62 Million | CN¥68.26 Million | CN¥212.08 Million | ▲ +3254.9% |
| 2008 | 0.01x | CN¥2.36 Million | CN¥-11.72 Million | CN¥210.84 Million | ▼ -96.1% |
| 2007 | 0.28x | CN¥58.13 Million | CN¥23.08 Million | CN¥204.51 Million | — |